RHEACELL GmbH & Co. KG
PrivateLast Round
Corporate Funding
Jul 30, 2020
Total Funding Raised
$70.71M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
RHEACELL GmbH & Co. KG operates in Healthcare & Life Sciences and is based in Heidelberg. Its latest recorded funding round was a Corporate Funding round in July 2020.
RHEACELL GmbH & Co. KG is a biopharmaceutical company that develops innovative stem cell-based therapies for severe immune and inflammation-driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RHEACELL GmbH & Co. KG Comparables
Compare RHEACELL GmbH & Co. KG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Castle Creek Biosciences | 74% | |
| Abeona Therapeutics Inc. | 74% | |
| Longeveron | 74% |
For institutional investors. Book with your work email.
RHEACELL GmbH & Co. KG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 30, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 45% MoM.
- Aug 21, 2026
Monthly visitors grew 68% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
RHEACELL GmbH & Co. KG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RHEACELL GmbH & Co. KG's valuation, stock price, and market status.
Is RHEACELL GmbH & Co. KG a public or private company?
RHEACELL GmbH & Co. KG is a private company.
What is the current stock price of RHEACELL GmbH & Co. KG?
RHEACELL GmbH & Co. KG is a private company, so its shares have no public market price. Caplight tracks RHEACELL GmbH & Co. KG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RHEACELL GmbH & Co. KG worth (valuation)?
Valuation information for RHEACELL GmbH & Co. KG is not publicly available.
Can I buy RHEACELL GmbH & Co. KG stock?
RHEACELL GmbH & Co. KG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RHEACELL GmbH & Co. KG's last funding round?
RHEACELL GmbH & Co. KG's most recent funding round was Corporate Funding on July 30, 2020.
Who are the main investors in RHEACELL GmbH & Co. KG?
Investor information for RHEACELL GmbH & Co. KG is not publicly disclosed.
Will RHEACELL GmbH & Co. KG IPO soon?
No public IPO plans have been announced for RHEACELL GmbH & Co. KG.
How can I track RHEACELL GmbH & Co. KG secondary market activity?
Caplight tracks bids, offers, and trades in RHEACELL GmbH & Co. KG's shares on secondary markets.